Tops & Flops Stocks
Security | Change (%) | 1w | 1m | 1y ▼ | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Phibro Animal Health Corp. A | 3.110% | 7.792% | 37.190% | 30.709% | 61.165% | -25.225% | -34.426% |
Regeneron Pharmaceuticals Inc. | -1.270% | 1.057% | 6.317% | 30.167% | 12.702% | 111.333% | 228.449% |
Geron Corp. | 5.650% | 0.787% | 10.366% | 28.051% | 82.317% | 207.719% | 130.591% |
Capricor Therapeutics Inc | 1.980% | 0.307% | -10.980% | 27.901% | 9.609% | 63.500% | - |
United Therapeutics | 0.840% | 3.128% | 13.138% | 27.176% | 26.406% | 53.742% | 210.341% |
Catalyst Pharmaceutical Partners Inc | -0.130% | 11.838% | 5.588% | 26.749% | -1.512% | 236.966% | 409.827% |
Evolus Inc | - | -4.132% | 4.505% | 26.087% | 28.177% | 57.823% | - |
Vertex Pharmaceuticals Inc. | 1.500% | 3.182% | 7.513% | 25.421% | 8.193% | 124.888% | 168.317% |
IQVIA Holdings Inc. | 0.700% | 1.273% | -1.287% | 23.875% | 2.530% | 11.469% | - |
Innoviva Inc. | -1.340% | 2.817% | 5.797% | 22.689% | 0.000% | 37.736% | - |
Celldex Therapeutics | 0.550% | -3.646% | 0.543% | 20.915% | 2.210% | 67.877% | 596.798% |
Charles River Labs Intl | -0.420% | -2.374% | -3.650% | 20.893% | 0.376% | -21.397% | - |
Corcept Therapeutics Inc. | 0.820% | 8.076% | 17.194% | 15.135% | -14.800% | 46.057% | - |
Repligen Corp. | 0.660% | 5.063% | 3.352% | 14.301% | -3.431% | 14.382% | - |
Immucell Corp | -3.210% | 2.119% | 3.433% | 14.218% | 9.050% | -37.403% | -12.507% |
Merck & Co. Inc. | 1.510% | 0.498% | 2.020% | 13.060% | 23.046% | 88.053% | 74.665% |
AbbVie Inc. | 0.790% | 0.844% | -1.065% | 11.677% | 7.452% | 57.009% | 113.866% |
Biolife Solutions Inc | - | 10.526% | 31.250% | 11.176% | 26.846% | -21.053% | 20.875% |
Beximco Pharmaceuticals Ltd. GDR | -9.800% | 5.238% | 5.238% | 11.055% | 0.455% | -52.216% | -21.770% |
Ionis Pharmaceuticals Inc. | 0.230% | -3.586% | -7.852% | 10.082% | -21.108% | 14.454% | -39.210% |
Ligand Pharmaceuticals | -4.320% | 4.000% | 3.311% | 9.859% | 20.000% | -23.828% | -22.047% |
Champions Oncology Inc | -2.710% | -0.922% | -7.328% | 9.694% | -10.788% | -42.282% | - |
Actinium Pharmaceuticals Inc. | -2.520% | 10.575% | 12.524% | 9.024% | 97.788% | 52.821% | - |
Exelixis Inc. | -1.060% | -4.595% | -9.403% | 8.343% | -11.266% | -6.838% | 13.339% |
Cytomx Therapeutics Inc | 1.170% | -53.237% | -2.378% | 8.144% | 29.370% | -73.145% | - |